Specifically, we were able to identify CpGs that experienced a gain in DNA methylation in vehicle-treated MSCs compared to healthy controls at the same genomic loci previously identified in human MM-MSCs, including HOXA7, -B4, -B7, -B9, and -D10 (Fig. 6I and Supplementary Data 9). Here, HOXA7 is linked to Miyoshi myopathy.